Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Nektar Therapeutics (NKTR)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q3 | 0 | 0.00 | Sell 100.00% | 0.30 | SEC | ||
| 2022 Q2 | 3,218,382 | 0.30 | Reduce 32.85% | 0.15 | $3.80 | $12,230,000 | SEC |
| 2022 Q1 | 4,792,920 | 0.47 | Reduce 17.68% | 0.16 | $5.39 | $25,834,000 | SEC |
| 2021 Q4 | 5,822,604 | 0.89 | Reduce 0.27% | <0.01 | $13.51 | $78,663,000 | SEC |
| 2021 Q3 | 5,838,426 | 1.06 | Add 1.34% | 0.01 | $17.96 | $104,858,000 | SEC |
| 2021 Q2 | 5,761,073 | 0.94 | Reduce 1.66% | 0.02 | $17.16 | $98,860,000 | SEC |
| 2021 Q1 | 5,858,316 | 1.07 | Reduce 11.98% | 0.22 | $20.00 | $117,166,000 | SEC |
| 2020 Q4 | 6,655,625 | 1.81 | Add 17.21% | 0.27 | $17.00 | $113,146,000 | SEC |
| 2020 Q3 | 5,678,221 | 1.75 | Add 9.48% | 0.15 | $16.59 | $94,202,000 | SEC |
| 2020 Q2 | 5,186,637 | 2.53 | Add 5.88% | 0.14 | $23.16 | $120,123,000 | SEC |
| 2020 Q1 | 4,898,401 | 1.85 | Add 51.13% | 0.63 | $17.85 | $87,436,000 | SEC |
| 2019 Q4 | 3,241,234 | 1.02 | Buy | 1.02 | $21.58 | $69,962,000 | SEC |
| 2005 Q1 | 0 | 0.00 | Sell 100.00% | 0.69 | SEC | ||
| 2004 Q4 | 2,472,478 | 0.69 | Buy | 0.69 | $20.24 | $50,043,000 | SEC |